Less Ads, More Data, More Tools Register for FREE

UPDATE 1-French vaccine chief expects AstraZeneca vaccine halt to be temporary

Tue, 16th Mar 2021 08:07

(Adds more comments)

PARIS, March 16 (Reuters) - French vaccination chief Alain
Fischer said on Tuesday he expects the suspension of AstraZeneca
COVID-19 shots to be temporary.

Germany, France and Italy said on Monday they would suspend
AstraZeneca inoculations after several countries reported
possible serious side-effects, but the World Health Organization
said there was no proven link and people should not panic.

Fischer told France Inter radio that the number of cases of
people showing adverse side-effects was small.

"The ultimate element of analysis is the benefit-risk,
whatever happens", he said.

He also said that Anglo-Swedish AstraZeneca's vaccine was
not second tier.

"Vaccination is moving forward. Vaccination is here and will
continue," Fischer said.

Industry Minister Agnes Pannier-Runacher said France's
decision had been taken in co-ordination with other European
countries.
(Reporting by Sudip Kar-Gupta and Matthieu Protard, editing by
Louise Heavens and Nick Macfie)

Related Shares

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...

28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...

27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.